Better

Delivering digital tools and diagnostics
to improve infant outcomes

A Focus on the First 1,000 Days

Starting at conception, the health of both mother and child are of utmost importance. At Astarte Medical, we view the first 1,000 days as a window of opportunity to deliver solutions that allow hospitals and clinical teams to standardize care protocols and customize treatment plans, at a time that has a profound impact on long-term health.

These first 1,000 days are especially critical for preterm infants, who are facing significant challenges, which include:

50%
Growth
Failure
Greater Risk of
Allergy, Asthma
and Obesity
>40%
Neurodevelopmental
Delays or Disabilities

Featured Resource

06.01.20
Astarte Medical – The Nutrition Story
New video on the importance of early life nutrition for preterm infants

 

Core to Astarte Medical is our comprehensive and proprietary dataset, which integrates feeding protocols, microbiome profiles and clinical information. Our NICUtrition® suite of products provides actionable information in real time to hospitals and clinical teams, enabling them to standardize care protocols, and customize treatment plans by quantifying preterm infant gut health.

About Astarte Medical

Led by a distinguished team and world-class advisors in neonatology, nutrition and microbiome, Astarte Medical is the only precision nutrition company using software and predictive analytics to improve outcomes during the first 1,000 days of life, with an initial focus on preterm infants.

Featured News

10.20.20 | Press Release

Astarte Medical Announces Issuance of U.S. Patent Covering A Digital Gut Health Diagnostic

09.28.20 | article

Tracy Warren discusses Building a Business Case for Nutrition Technology in the NICU

09.08.20 | Press Release

Astarte Medical is One of Five Early Stage Companies Selected for 2020 Program

Events

Event

Marc Masor, PhD, discusses The Challenges of Preterm Infant Formula Development

Event

Live Interactive Online Conference